Synthesis, Characterization and Biological Evaluation of Some Novel 1,3,4-Oxadiazole Derivatives as Potential Anticancer Agents

Akshay R. Yadav; Shrinivas K. Mohite; Chandrakant S. Magdum

doi:10.32628/IJSRST207234

Authors

Akshay R. Yadav Department of Pharmaceutical Chemistry, Rajarambapu college of Pharmacy, Kasegaon, Maharashtra, India
Shrinivas K. Mohite Department of Pharmaceutical Chemistry, Rajarambapu college of Pharmacy, Kasegaon, Maharashtra, India
Chandrakant S. Magdum Department of Pharmaceutical Chemistry, Rajarambapu college of Pharmacy, Kasegaon, Maharashtra, India

DOI:

https://doi.org//10.32628/IJSRST207234

Keywords:

1,3,4-Oxadiazole, microwave, anticancer, MCF7, SwissADME

Abstract

A new Series of novel N-Substituted 1,3,4-Oxadiazole derivatives (3a-3f) were synthesized by the reacting 3,5-dinitrobenzoic acid and subsequent treatment with thiourea by microwave assisted synthesis as green chemistry. Confirmation of the chemical structure of the synthesized compounds was substantiated by TLC, IR, 1HNMR, and MS spectroscopy. Synthesized compounds were screened for anticancer activity on MCF7 cell line. All synthesized compounds exhibit significant biological activity and certainly hold a greater promise for discovering potent biologically active molecules. Further the compounds 3b, 3c and 3e has been moderate tested for its anticancer activity and out of these all, compound 3c showed most notable anticancer activity against breast cancer cell line. Molecules under study were analysed for ADME properties using SwissADME servers. ADME profiles were evaluated and most of the molecules were found to be suitable for further studies. In silico ADMET analysis is proved to be a good tool in drug discovery.

References

Ahsan M, Rathod V, Singh V, Singh M , Sharma R, Jadhav S, Yasmin S, Kumar P, “ Synthesis, anticancer and molecular docking studies of 2-(4-chlorophenyl)-5-aryl-1,3,4-oxadiazole analogues”. 2013. Med chem. 3(4): 294-297.
Shah R, Rosso K, Nathanson S, “Pathogenesis, prevention, diagnosis and treatment of breast cancer”. 2014. world J Clin Oncol. 5(3): 283-298.
Bala S, Khamboj S, Kajal A, Saini V, Prasad D, “1,3,4-oxadiazole derivatives: Synthesis, characterization, antimicrobial potential, and computational studies”. 2014. Bio med Res Int: 1-18.
Rashid M, Husain A, Mishra R, Karim S, Khan S, Ahmad M, Al-wabel N, Husain A, Ahmed A, Khan S, “Design and synthesis of benzimidazoles containing substituted oxadiazole, thiadiazole and triazolo-thiadiazines as a source of new anticancer agents”. 2015. Arab. J. Chem: 1-23.
Shridhar A, Keshavayya, Peethamber, Hoskeri H, “ Synthesis and biological activites of Bis alkyl 1,3,4-oxadiazole incorporated azo dye derivatives”. 2012. Arab. J. Chem: 1-6.
Chandrakantha B, Shetty P, Nambiiyar V, Isloor N, Isloor A, “Synthesis, characterization and biological activity of some new 1,3,4-oxadiazole bearing 2-fluoro-4-methoxy phenyl moiety”. 2010. Eur. J. Med. Chem. 45: 1206-1210.
Yadav A, Mohite S, “Design, Synthesis and Characterization of Some Novel benzamide derivatives and it’s Pharmacological Screening”. 2020. Int J Sci Res Sci Technol. 7(2): 68-74.
Gaonkar S, Rai K, Prabhuswamy, “Synthesis and antimicrobial studies of a new series of 2-{4-2-(5-ethylpyridin-2-yl)ethoxy]phenyl}-5-substituted-1,3,4-oxadiazoles”. 2006. Eur. J. Med. Chem. 41: 841-846.
Vishwanathan B, Gurupadayya B, Sairam V, Inturi B, “Design, synthesis, in vitro antioxidant and in vivo anti-inflammatory activities of novel oxadiazole derivatives”. 2014. Int J Pharm Pharm Sci. 6(9): 514-520.
Ali S, Jabbir A, Rana A, Mohsie B, “Synthesis of Some Sulfa drugs Derivatives as Antibacterial Agent” 2016, Micro. J. Ap. Sci. 5: 75-83.
Patel M, Modi N, Ravalb J, Menon S, “Calix4]arene based 1,3,4-oxadiazole and thiadiazole derivatives: Design, synthesis, and biological evaluation” 2012, Org. Biomol. Chem. 10: 1785–1794
Salih N, Salimon J, Yousif E, “Synthesis and Antimicrobial Evaluation of 5-(p-substituted phenyl)-N-(3-(5-nitrofur-2-yl) allylidene)-1,3,4-thiadiazol-2-amine Derivatives”, 2011, Orient. J. Chem. 27(2): 373-383.
Yamada N, Kataoka Y, Nagami T, Hong S, Kawai S, Kuwano E, “5-Aryl-1,3,4-oxadiazole-2-thiols as a New Series of trans-Cinnamate 4-Hydroxylase Inhibitors”, 2004, J. Pestic. Sci. 29(3),: 205–208
Daina A, Michielin O, Zoete V, “SwissADME: a free web tool to evaluate pharmacokinetics, druglikeness and medicinal chemistry friendliness of small molecules” Sci. Rep:1-13.
Subbhaiah N, Mohanty S, Sudha B, Ayyana C, “Synthesis, characterization and evaluation of antibacterial & anti-fungal activity of 2,5-disubstituted 1,3,4-oxadiazole derivatives”. 2016. Int J Pharm Pharm Sci. 1(2) : 39-42.
Cell viability testing with tryphan exclusion method, social & scientific systems, INC. National institute of environmental health sciences:1-2.
Freitas B, Almeida V, Pinto M, Mourao F, Massensini A, Filho O, Viera E, Melo G, “ Tryphan blue exclusion assay by flow cytometry”. 2014. Braz J Med Biol. 47(4): 307-315.
Lohidashan K, Rajan, Andhale G, Paul M, Jerin J, “Pass and Swiss ADME collaborated in silico docking approach to the synthesis of certain pyrazoline spacer compounds for dihydrofolate reductase inhibition and antimalarial activity”.2018. Bangladesh J Pharmacol. 13: 23-29.
Ali A, Badawy M, Shah R, Rehman W, Kilney Y, Ashry E, Tahir N,” Synthesis, characterization and In-Silico ADMET Screening of Mono-Di-carbomethoxylated 6,6’-Methylrnrbis(2-cyclohexyl-4-methylphenol) and their hydrazides and hydrazones”. 2017. Der Chem. Sin. 8(4): 446-460.
Kumar R, Giri A, Nadendla R, “Insilico ADME profiling of CDK9 inhibitors”. 2018. J